666

SHANGHAI YIZHONG PHARMACEUTICAL CO.,LTD.

No trades
See on Supercharts
Market capitalization
‪6.17 B‬CNY
‪161.55 M‬CNY
‪358.64 M‬CNY
‪75.94 M‬
Beta (1Y)
1.22

About SHANGHAI YIZHONG PHARMACEUTICAL CO.,LTD.

CEO
Jin Song Zhou
Headquarters
Shanghai
Employees (FY)
304
Founded
2009
ISIN
CNE1000050F4
FIGI
BBG00WMGBXJ4
Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of anti-tumor drugs and related pharmaceutical products. The company was founded by Jin Song Zhou and Duan Li on September 10, 2009 and is headquartered in Shanghai, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 688091 is 39.93 CNY — it has increased by 2.38% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange SHANGHAI YIZHONG PHARMACEUTICAL CO.,LTD. stocks are traded under the ticker 688091.
688091 stock is 4.23% volatile and has beta coefficient of 1.22. Check out the list of the most volatile stocks — is SHANGHAI YIZHONG PHARMACEUTICAL CO.,LTD. there?
Yes, you can track SHANGHAI YIZHONG PHARMACEUTICAL CO.,LTD. financials in yearly and quarterly reports right on TradingView.
688091 stock has risen by 1.11% compared to the previous week, the month change is a 17.24% fall, over the last year SHANGHAI YIZHONG PHARMACEUTICAL CO.,LTD. has showed a 54.10% decrease.
688091 net income for the last quarter is ‪30.93 M‬ CNY, while the quarter before that showed ‪26.51 M‬ CNY of net income which accounts for 16.65% change. Track more SHANGHAI YIZHONG PHARMACEUTICAL CO.,LTD. financial stats to get the full picture.
Today SHANGHAI YIZHONG PHARMACEUTICAL CO.,LTD. has the market capitalization of ‪6.17 B‬, it has decreased by 2.62% over the last week.
Yes, 688091 dividends are paid annually. The last dividend per share was 0.30 CNY. As of today, Dividend Yield (TTM)% is 0.70%. Tracking SHANGHAI YIZHONG PHARMACEUTICAL CO.,LTD. dividends might help you take more informed decisions.
SHANGHAI YIZHONG PHARMACEUTICAL CO.,LTD. dividend yield was 0.48% in 2023, and payout ratio reached 30.37%. The year before the numbers were 0.43% and 30.22% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 688091 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI YIZHONG PHARMACEUTICAL CO.,LTD. stock right from TradingView charts — choose your broker and connect to your account.
688091 reached its all-time high on Jun 10, 2022 with the price of 132.94 CNY, and its all-time low was 25.68 CNY and was reached on Sep 22, 2021.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has 304.00 employees. See our rating of the largest employees — is SHANGHAI YIZHONG PHARMACEUTICAL CO.,LTD. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI YIZHONG PHARMACEUTICAL CO.,LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI YIZHONG PHARMACEUTICAL CO.,LTD. stock shows the strong sell signal. See more of SHANGHAI YIZHONG PHARMACEUTICAL CO.,LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHANGHAI YIZHONG PHARMACEUTICAL CO.,LTD. EBITDA is ‪167.75 M‬ CNY, and current EBITDA margin is 46.77%. See more stats in SHANGHAI YIZHONG PHARMACEUTICAL CO.,LTD. financial statements.